Answers are grounded in this paper and cite their sources.
These results indicate that MK-1775 selectively synergizes with GEM to achieve tumor regressions, selectively in p53-deficient pancreatic cancer xenografts.
No takes yet. Share an insight, caveat, or question.
Rajeshkumar et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: